{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T19:19:37Z","timestamp":1793647177947,"version":"4.5.1"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"Dr Reddys Laboratories Ltd."}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drugs - Real World Outcomes"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1007\/s40801-023-00400-3","type":"journal-article","created":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T10:03:11Z","timestamp":1701424991000},"page":"167-176","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Clinical and Demographic Characteristics of Patients with Coexistent Hypertension, Type 2 Diabetes Mellitus, and Dyslipidemia: A Retrospective Study from India"],"prefix":"10.1007","volume":"11","author":[{"given":"Jamshed","family":"Dalal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Praveen","family":"Chandra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajeev","family":"Chawla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viveka","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jabir","family":"Abdullakutty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vidhya","family":"Natarajan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syed Mujtaba Hussain","family":"Naqvi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kumar","family":"Gaurav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahul","family":"Rathod","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gauri","family":"Dhanaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhavesh","family":"Kotak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Snehal","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,12,1]]},"reference":[{"key":"400_CR1","doi-asserted-by":"publisher","DOI":"10.1038\/ncpendmet1066","author":"AD Mooradian","year":"2009","unstructured":"Mooradian AD. Dyslipidemia in type 2 diabetes mellitus. Nat Clin Pract Endocrinol Metab. 2009. https:\/\/doi.org\/10.1038\/ncpendmet1066.","journal-title":"Nat Clin Pract Endocrinol Metab"},{"key":"400_CR2","unstructured":"WHO. Global report on diabetes. Accessed from https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/204871\/9789241565257_eng.pdf. On 10th Dec 2022."},{"key":"400_CR3","unstructured":"International Diabetes Federation. IDF diabetes Atlas. Accessed from https:\/\/diabetesatlas.org\/. On 10th Dec 2022."},{"key":"400_CR4","doi-asserted-by":"publisher","DOI":"10.1038\/sj.jhh.1001633","author":"R Gupta","year":"2004","unstructured":"Gupta R. Trends in hypertension epidemiology in India. J Hum Hypertens. 2004. https:\/\/doi.org\/10.1038\/sj.jhh.1001633.","journal-title":"J Hum Hypertens"},{"key":"400_CR5","doi-asserted-by":"publisher","DOI":"10.1097\/hjh.0000000000000146","author":"R Anchala","year":"2014","unstructured":"Anchala R, Kannuri NK, Pant H, et\u00a0al. Hypertension in India: a systematic review and meta-analysis of prevalence, awareness, and control of hypertension. J Hypertens. 2014. https:\/\/doi.org\/10.1097\/hjh.0000000000000146.","journal-title":"J Hypertens"},{"key":"400_CR6","unstructured":"National Health Portal of India. Dyslipidemia. Accessed from https:\/\/www.nhp.gov.in\/dyslipidemia_mtl#:~:text=In%20India%20approximately%2025%2D30,are%20more%20prone%20than%20women. On 11th Dec 2022."},{"key":"400_CR7","doi-asserted-by":"publisher","DOI":"10.4103\/2229-516x.157170","author":"K Nsiah","year":"2015","unstructured":"Nsiah K, Shang VO, Boateng KA, Mensah FO. Prevalence of metabolic syndrome in type 2 diabetes mellitus patients. Int J Appl Basic Med Res. 2015. https:\/\/doi.org\/10.4103\/2229-516x.157170.","journal-title":"Int J Appl Basic Med Res"},{"key":"400_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/nrendo.2017.151","author":"Y Zheng","year":"2018","unstructured":"Zheng Y, Ley SH, Hu FB. Global aetiology and epidemiology of type 2 diabetes mellitus and its complications. Nat Rev Endocrinol. 2018. https:\/\/doi.org\/10.1038\/nrendo.2017.151.","journal-title":"Nat Rev Endocrinol"},{"key":"400_CR9","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.54.6.1615","author":"M Brownlee","year":"2005","unstructured":"Brownlee M. The pathobiology of diabetic complications: a unifying mechanism. Diabetes. 2005. https:\/\/doi.org\/10.2337\/diabetes.54.6.1615.","journal-title":"Diabetes"},{"key":"400_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.cjca.2017.12.005","author":"JR Petrie","year":"2018","unstructured":"Petrie JR, Guzik TJ, Touyz RM. Diabetes, hypertension, and cardiovascular disease: clinical insights and vascular mechanisms. Can J Cardiol. 2018. https:\/\/doi.org\/10.1016\/j.cjca.2017.12.005.","journal-title":"Can J Cardiol"},{"key":"400_CR11","doi-asserted-by":"publisher","DOI":"10.2337\/cd22-as01","author":"American Diabetes Association","year":"2022","unstructured":"American Diabetes Association. Standards of medical care in diabetes-2022 abridged for primary care providers. Clin Diabetes. 2022. https:\/\/doi.org\/10.2337\/cd22-as01.","journal-title":"Clin Diabetes."},{"key":"400_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.tcm.2019.05.003","author":"JM Flack","year":"2020","unstructured":"Flack JM, Adekola B. Blood pressure and the new ACC\/AHA hypertension guidelines. Trends Cardiovasc Med. 2020. https:\/\/doi.org\/10.1016\/j.tcm.2019.05.003.","journal-title":"Trends Cardiovasc Med"},{"key":"400_CR13","doi-asserted-by":"publisher","unstructured":"Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA. 2001. https:\/\/doi.org\/10.1001\/jama.285.19.2486.","DOI":"10.1001\/jama.285.19.2486"},{"key":"400_CR14","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/5528007","author":"L Qiu","year":"2021","unstructured":"Qiu L, Wang W, Sa R, Liu F. Prevalence and risk factors of hypertension, diabetes, and dyslipidemia among adults in Northwest China. Int J Hypertens. 2021. https:\/\/doi.org\/10.1155\/2021\/5528007.","journal-title":"Int J Hypertens"},{"key":"400_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2017.03.024","author":"K Ogurtsova","year":"2017","unstructured":"Ogurtsova K, da Rocha Fernandes JD, Huang Y, et\u00a0al. IDF diabetes Atlas: global estimates for the prevalence of diabetes for 2015 and 2040. Diabetes Res Clin Pract. 2017. https:\/\/doi.org\/10.1016\/j.diabres.2017.03.024.","journal-title":"Diabetes Res Clin Pract"},{"key":"400_CR16","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2458-12-380","author":"R Jayawardena","year":"2012","unstructured":"Jayawardena R, Ranasinghe P, Byrne NM, et\u00a0al. Prevalence and trends of the diabetes epidemic in South Asia: a systematic review and meta-analysis. BMC Public Health. 2012. https:\/\/doi.org\/10.1186\/1471-2458-12-380.","journal-title":"BMC Public Health"},{"key":"400_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2015.05.039","author":"RM Anjana","year":"2015","unstructured":"Anjana RM, Sudha V, Nair DH, et\u00a0al. Diabetes in Asian Indians-How much is preventable? Ten-year follow-up of the Chennai Urban Rural Epidemiology Study (CURES-142). Diabetes Res Clin Pract. 2015. https:\/\/doi.org\/10.1016\/j.diabres.2015.05.039.","journal-title":"Diabetes Res Clin Pract"},{"key":"400_CR18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0163891","author":"T Mahapatra","year":"2016","unstructured":"Mahapatra T, Chakraborty K, Mahapatra S, et\u00a0al. Burden and socio-behavioral correlates of uncontrolled abnormal glucose metabolism in an urban population of India. PLoS ONE. 2016. https:\/\/doi.org\/10.1371\/journal.pone.0163891.","journal-title":"PLoS ONE"},{"key":"400_CR19","doi-asserted-by":"publisher","DOI":"10.4172\/2161-1165.1000224","author":"S Kanungo","year":"2016","unstructured":"Kanungo S, Mahapatra T, Bhowmik K, et\u00a0al. Diabetes scenario in backward rural district population of India and need for restructuring health care delivery services. Epidemiol. 2016. https:\/\/doi.org\/10.4172\/2161-1165.1000224.","journal-title":"Epidemiol"},{"key":"400_CR20","doi-asserted-by":"publisher","DOI":"10.1161\/circulationaha.115.018912","author":"KT Mills","year":"2016","unstructured":"Mills KT, Bundy JD, Kelly TN, et\u00a0al. Global disparities of hypertension prevalence and control: a systematic analysis of population-based studies from 90 countries. Circulation. 2016. https:\/\/doi.org\/10.1161\/circulationaha.115.018912.","journal-title":"Circulation"},{"key":"400_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.lansea.2022.100113","author":"SF Koya","year":"2022","unstructured":"Koya SF, Pilakkadavath Z, Chandran P, et\u00a0al. Hypertension control rate in India: Systematic review and meta-analysis of population-level non-interventional studies, 2001\u20132022. Lancet Region Health. 2022. https:\/\/doi.org\/10.1016\/j.lansea.2022.100113.","journal-title":"Lancet Region Health."},{"key":"400_CR22","doi-asserted-by":"publisher","DOI":"10.1186\/s13690-022-00996-y","author":"S Dey","year":"2022","unstructured":"Dey S, Mukherjee A, Pati MK, et\u00a0al. Socio-demographic, behavioural and clinical factors influencing control of diabetes and hypertension in urban Mysore, South India: a mixed-method study conducted in 2018. Arch Public Health. 2022. https:\/\/doi.org\/10.1186\/s13690-022-00996-y.","journal-title":"Arch Public Health."},{"key":"400_CR23","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2021.778235","author":"A Sreedevi","year":"2022","unstructured":"Sreedevi A, Krishnapillai V, Menon VB, et\u00a0al. Uncontrolled blood pressure and associated factors among persons with diabetes: a community based study from Kerala, India. Front Public Health. 2022. https:\/\/doi.org\/10.3389\/fpubh.2021.778235.","journal-title":"Front Public Health"},{"key":"400_CR24","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0096808","author":"SR Joshi","year":"2014","unstructured":"Joshi SR, Anjana RM, Deepa M, et\u00a0al. Prevalence of dyslipidemia in urban and rural India: the ICMR-INDIAB study. PLoS ONE. 2014. https:\/\/doi.org\/10.1371\/journal.pone.0096808.","journal-title":"PLoS ONE"},{"key":"400_CR25","doi-asserted-by":"publisher","DOI":"10.2337\/diab.37.12.1595","author":"GM Reaven","year":"1988","unstructured":"Reaven GM. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes. 1988. https:\/\/doi.org\/10.2337\/diab.37.12.1595.","journal-title":"Diabetes"},{"key":"400_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(04)17018-9","author":"S Yusuf","year":"2004","unstructured":"Yusuf S, Hawken S, Ounpuu S, et\u00a0al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case\u2013control study. Lancet. 2004. https:\/\/doi.org\/10.1016\/s0140-6736(04)17018-9.","journal-title":"Lancet"},{"key":"400_CR27","doi-asserted-by":"publisher","DOI":"10.1111\/j.1751-7176.2010.00386.x","author":"P Deedwania","year":"2011","unstructured":"Deedwania P. Hypertension, dyslipidemia, and insulin resistance in patients with diabetes mellitus or the cardiometabolic syndrome: benefits of vasodilating \u03b2-blockers. J Clin Hypertens. 2011. https:\/\/doi.org\/10.1111\/j.1751-7176.2010.00386.x.","journal-title":"J Clin Hypertens"},{"key":"400_CR28","doi-asserted-by":"publisher","DOI":"10.1161\/01.cir.0000141736.76561.78","author":"A Prasad","year":"2004","unstructured":"Prasad A, Quyyumi AA. Renin-angiotensin system and angiotensin receptor blockers in the metabolic syndrome. Circulation. 2004. https:\/\/doi.org\/10.1161\/01.cir.0000141736.76561.78.","journal-title":"Circulation"},{"key":"400_CR29","doi-asserted-by":"publisher","DOI":"10.1056\/nejm198708063170605","author":"E Ferrannini","year":"1987","unstructured":"Ferrannini E, Buzzigoli G, Bonadonna R, et\u00a0al. Insulin resistance in essential hypertension. N Engl J Med. 1987. https:\/\/doi.org\/10.1056\/nejm198708063170605.","journal-title":"N Engl J Med"},{"key":"400_CR30","doi-asserted-by":"publisher","DOI":"10.1194\/jlr.m038638","author":"A Giordano","year":"2013","unstructured":"Giordano A, Murano I, Mondini E, et\u00a0al. Obese adipocytes show ultrastructural features of stressed cells and die of pyroptosis. J Lipid Res. 2013. https:\/\/doi.org\/10.1194\/jlr.m038638.","journal-title":"J Lipid Res"},{"key":"400_CR31","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/cvx116","author":"C Antoniades","year":"2017","unstructured":"Antoniades C. \u201cDysfunctional\u201d adipose tissue in cardiovascular disease: a reprogrammable target or an innocent bystander? Cardiovasc Res. 2017. https:\/\/doi.org\/10.1093\/cvr\/cvx116.","journal-title":"Cardiovasc Res"},{"key":"400_CR32","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-08444-6","author":"S Camastra","year":"2017","unstructured":"Camastra S, Vitali A, Anselmino M, et\u00a0al. Muscle and adipose tissue morphology, insulin sensitivity and beta-cell function in diabetic and nondiabetic obese patients: effects of bariatric surgery. Sci Rep. 2017. https:\/\/doi.org\/10.1038\/s41598-017-08444-6.","journal-title":"Sci Rep"},{"key":"400_CR33","doi-asserted-by":"publisher","DOI":"10.4061\/2011\/281240","author":"C Savoia","year":"2011","unstructured":"Savoia C, Sada L, Zezza L, et\u00a0al. Vascular inflammation and endothelial dysfunction in experimental hypertension. Int J Hypertens. 2011. https:\/\/doi.org\/10.4061\/2011\/281240.","journal-title":"Int J Hypertens"},{"key":"400_CR34","doi-asserted-by":"publisher","DOI":"10.1056\/nejm199604113341504","author":"JP Despr\u00e9s","year":"1996","unstructured":"Despr\u00e9s JP, Lamarche B, Mauri\u00e8ge P, et\u00a0al. Hyperinsulinemia as an independent risk factor for ischemic heart disease. N Engl J Med. 1996. https:\/\/doi.org\/10.1056\/nejm199604113341504.","journal-title":"N Engl J Med"},{"key":"400_CR35","doi-asserted-by":"publisher","DOI":"10.2337\/diab.41.6.715","author":"SM Haffner","year":"1992","unstructured":"Haffner SM, Valdez RA, Hazuda HP, Mitchell BD, Morales PA, Stern MP. Prospective analysis of the insulin-resistance syndrome (syndrome X). Diabetes. 1992. https:\/\/doi.org\/10.2337\/diab.41.6.715.","journal-title":"Diabetes"},{"key":"400_CR36","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.164.17.1850","author":"JR Sowers","year":"2004","unstructured":"Sowers JR. Treatment of hypertension in patients with diabetes. Arch Intern Med. 2004. https:\/\/doi.org\/10.1001\/archinte.164.17.1850.","journal-title":"Arch Intern Med"},{"key":"400_CR37","doi-asserted-by":"publisher","DOI":"10.1161\/01.hyp.19.5.403","author":"M Epstein","year":"1992","unstructured":"Epstein M, Sowers JR. Diabetes mellitus and hypertension. Hypertension. 1992. https:\/\/doi.org\/10.1161\/01.hyp.19.5.403.","journal-title":"Hypertension"},{"key":"400_CR38","doi-asserted-by":"publisher","DOI":"10.1056\/nejm200003303421301","author":"TW Gress","year":"2000","unstructured":"Gress TW, Nieto FJ, Shahar E, Wofford MR, Brancati FL. Hypertension and antihypertensive therapy as risk factors for type 2 diabetes mellitus. Atherosclerosis risk in communities study. N Engl J Med. 2000. https:\/\/doi.org\/10.1056\/nejm200003303421301.","journal-title":"N Engl J Med"},{"key":"400_CR39","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.00026.2004","author":"JR Sowers","year":"2004","unstructured":"Sowers JR. Insulin resistance and hypertension. Am J Physiol Heart Circ Physiol. 2004. https:\/\/doi.org\/10.1152\/ajpheart.00026.2004.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"400_CR40","doi-asserted-by":"publisher","DOI":"10.1007\/s11906-004-0072-y","author":"F El-Atat","year":"2004","unstructured":"El-Atat F, McFarlane SI, Sowers JR. Diabetes, hypertension, and cardiovascular derangements: pathophysiology and management. Curr Hypertens Rep. 2004. https:\/\/doi.org\/10.1007\/s11906-004-0072-y.","journal-title":"Curr Hypertens Rep"},{"key":"400_CR41","doi-asserted-by":"publisher","DOI":"10.1161\/01.hyp.37.4.1053","author":"JR Sowers","year":"2001","unstructured":"Sowers JR, Epstein M, Frohlich ED. Diabetes, hypertension, and cardiovascular disease: an update. Hypertension. 2001. https:\/\/doi.org\/10.1161\/01.hyp.37.4.1053.","journal-title":"Hypertension"},{"key":"400_CR42","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.321.7258.412","author":"AI Adler","year":"2000","unstructured":"Adler AI, Stratton IM, Neil HA, et\u00a0al. Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study. BMJ. 2000. https:\/\/doi.org\/10.1136\/bmj.321.7258.412.","journal-title":"BMJ"},{"key":"400_CR43","doi-asserted-by":"publisher","DOI":"10.7860\/jcdr\/2016\/18806.7511","author":"A Verma","year":"2016","unstructured":"Verma A, Vyas S, Agarwal A, Abbas S, Agarwal DP, Kumar R. Diabetic kidney disease and hypertension: a true love story. J Clin Diagn Res. 2016. https:\/\/doi.org\/10.7860\/jcdr\/2016\/18806.7511.","journal-title":"J Clin Diagn Res"},{"key":"400_CR44","doi-asserted-by":"publisher","DOI":"10.1053\/j.ackd.2010.10.003","author":"PN Van Buren","year":"2011","unstructured":"Van Buren PN, Toto R. Hypertension in diabetic nephropathy: epidemiology, mechanisms, and management. Adv Chronic Kidney Dis. 2011. https:\/\/doi.org\/10.1053\/j.ackd.2010.10.003.","journal-title":"Adv Chronic Kidney Dis"},{"key":"400_CR45","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.161.9.1207","author":"J Coresh","year":"2001","unstructured":"Coresh J, Wei GL, McQuillan G, et\u00a0al. Prevalence of high blood pressure and elevated serum creatinine level in the United States: findings from the third National Health and Nutrition Examination Survey (1988\u20131994). Arch Intern Med. 2001. https:\/\/doi.org\/10.1001\/archinte.161.9.1207.","journal-title":"Arch Intern Med"},{"key":"400_CR46","doi-asserted-by":"publisher","DOI":"10.1111\/jch.14141","author":"P Kaur","year":"2021","unstructured":"Kaur P, Kunwar A, Sharma M, et\u00a0al. India hypertension control initiative-hypertension treatment and blood pressure control in a cohort in 24 sentinel site clinics. J Clin Hypertens. 2021. https:\/\/doi.org\/10.1111\/jch.14141.","journal-title":"J Clin Hypertens"},{"key":"400_CR47","doi-asserted-by":"publisher","DOI":"10.1007\/5584_2016_36","author":"JM Cruickshank","year":"2017","unstructured":"Cruickshank JM. The role of beta-blockers in the treatment of hypertension. Adv Exp Med Biol. 2017. https:\/\/doi.org\/10.1007\/5584_2016_36.","journal-title":"Adv Exp Med Biol"},{"key":"400_CR48","unstructured":"India Hypertension Control Initiative. 2021. Accessed from https:\/\/www.google.co.in\/url?sa=t&rct=j&q=&esrc=s&source=web&cd=&cad=rja&uact=8&ved=2ahUKEwjXgemNzJWBAxXxcmwGHfEzAH0QFnoECA8QAQ&url=https%3A%2F%2Flinkscommunity.org%2Fassets%2FPDFs%2Fhtn-draft-training-module_non-simple_05122019-for-print.pdf&usg=AOvVaw2fs2k4ZTrSmwuRfZMyd0nG&opi=89978449. On 06th Sept 2023."}],"container-title":["Drugs - Real World Outcomes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40801-023-00400-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40801-023-00400-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40801-023-00400-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,11]],"date-time":"2024-03-11T23:03:03Z","timestamp":1710198183000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40801-023-00400-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,1]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["400"],"URL":"https:\/\/doi.org\/10.1007\/s40801-023-00400-3","relation":{},"ISSN":["2199-1154","2198-9788"],"issn-type":[{"value":"2199-1154","type":"print"},{"value":"2198-9788","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,1]]},"assertion":[{"value":"10 October 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 December 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was funded by Dr. Reddy\u2019s Laboratories Ltd. And carried out by Healthplix Technologies.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"Dr. Jamshed Dalal, Dr. Praveen Chandra, Dr. Rajeev Chawla, Dr. Viveka Kumar, Dr. Jabir Abdullakutty, and Ms. Snehal Shah declare no conflicts of interest. Dr. Vidhya Natarajan, Dr. Syed Mujtaba Hussain Naqvi, Dr. Kumar Gaurav, Dr. Rahul Rathod, Ms. Gauri Dhanaki, and Dr. Bhavesh Kotak are employees of Dr. Reddy's Laboratories Ltd., which funded the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Anonymized and aggregated data is presented in the manuscript.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of data and material"}},{"value":"Ethics approval was obtained from the Suraksha Ethics Committee (ECR\/644\/Inst\/MH\/2014\/RR-20).","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent waiver was obtained from the Ethics Committee as this was a non-experimental, retrospective data analysis study.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}},{"value":"JD, PC, RC, VK, JA, VN, SMHN, KG, RR, GD, and BK contributed to conception, design, manuscript preparation, editing, and review. SS contributed to literature search, data acquisition, data analysis, and manuscript review. All authors have read and approved the final version of manuscript.","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author contributions"}}]}}